Previous 10 | Next 10 |
2023-11-06 12:36:20 ET Summary Customers in the biopharma industry are cutting spending, creating a soft demand environment for Schrodinger's software and drug discovery services. Despite the recent share price spike, Schrodinger's valuation is still low when accounting for all of...
Schrödinger (Nasdaq: SDGR), whose physics-based computational platform is transforming the way therapeutics and materials are discovered, today announced that management will participate in the following conferences in November: Jefferies London Healthcare Conference: Fireside chat...
2023-11-06 08:00:00 ET Summary The S&P 500 was up 5.9% for the week, and is just 5.0% below the 2023 high watermark. The best performer last week was Blockchain, as Bitcoin continues to gain upward momentum. After several weeks of narrowing market participation, it now loo...
2023-11-04 09:00:00 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Better-than-expected labor productivity data for the U.S. economy reported on Nov. 2 was the reason behind the huge stock market rally that day. “Non-farm productivity, which mea...
Schrödinger (Nasdaq: SDGR), whose physics-based computational platform is transforming the way therapeutics and materials are discovered, today announced that new data on SGR-1505, its investigational MALT1 inhibitor, and SGR-2921, its investigational CDC7 inhibitor, will be presented during...
2023-11-02 08:15:00 ET With the frothiness of the artificial intelligence (AI) craze in full swing, Schrödinger (NASDAQ: SDGR) is a biotech that investors should know about now. While many questions remain about the viability of its business model and its ability to grow in the...
2023-11-01 22:36:04 ET Schrödinger, Inc. (SDGR) Q3 2023 Results Earnings Conference Call November 1, 2023, 04:30 PM ET Company Participants Jaren Madden - Senior Vice President, Investor Relations and Corporate Communications Ramy Farid - President and Chief Exe...
2023-11-01 16:03:46 ET More on Schrödinger Schrodinger: Leading The AI Healthcare Revolution Schrodinger: More Than An AI Bubble Stock Schrodinger: A Computational Platform That Is Likely Becoming Obsolete Seeking Alpha’s Quant Rating on Schrö...
Delivers Third Quarter Total Revenue of $42.6 Million; Maintains Full-Year 2023 Revenue Guidance Continued Progress for SGR-1505, Healthy Volunteer Data Expected in Fourth Quarter of 2023 Phase 1 Study Initiated for SGR-2921; Discloses PRMT5-MTA Discovery Program BMS Retur...
Hitachi Construction Machinery Co. Ltd ADR (HTCMY) is expected to report for Q2 2024 DigitalBridge Group Inc. (DBRG) is expected to report $0 for Q3 2023 LY Corp ADR (YAHOY) is expected to report for Q2 2024 DT Midstream Inc. (DTM) is expected to report $0.9 for Q3 2023 Summit Mat...
News, Short Squeeze, Breakout and More Instantly...
Initiative initially funded by $10 million grant from the Bill & Melinda Gates Foundation Schrödinger, Inc. (Nasdaq: SDGR), whose physics-based computational platform is transforming the way therapeutics and materials are discovered, today announced that it is embarking on ...
Schrödinger (Nasdaq: SDGR), whose physics-based computational platform is transforming the way therapeutics and materials are discovered, will report its second quarter 2024 financial results on Wednesday, July 31, 2024, after the financial markets close. The company will host a conference c...
2024-07-14 09:50:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...